Jeremy Grantham Abbott Laboratories Transaction History
Grantham, Mayo, Van Otterloo & Co. LLC
- $30.8 Billion
- Q1 2025
A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Abbott Laboratories stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 8,107,583 shares of ABT stock, worth $1.08 Billion. This represents 3.49% of its overall portfolio holdings.
Number of Shares
8,107,583
Previous 7,896,939
2.67%
Holding current value
$1.08 Billion
Previous $893 Million
20.4%
% of portfolio
3.49%
Previous 3.0%
Shares
32 transactions
Others Institutions Holding ABT
# of Institutions
3,541Shares Held
1.38BCall Options Held
9.75MPut Options Held
8.87M-
Vanguard Group Inc Valley Forge, PA170MShares$22.7 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.5 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$10.4 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$8.93 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.78 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $234B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...